Waters NanoAcquity UPLC Coupled with Q-TOF Premier Mass Spectrometer

Overview

The Waters NanoAcquity UPLC coupled with Q-TOF Premier is a high-resolution, accurate-mass liquid chromatography–mass spectrometry (LC-MS) platform engineered for comprehensive characterization of complex biological and synthetic molecules. This integrated system leverages ultra-performance liquid chromatography (UPLC) separation—operating at pressures up to 15,000 psi—with orthogonal acceleration time-of-flight (oa-TOF) mass analysis to deliver sub-ppm mass accuracy, isotopic fidelity, and robust MS/MS fragmentation capability. The Q-TOF Premier employs a dual-stage quadrupole architecture combined with a reflectron TOF analyzer, enabling both precursor ion selection and high-resolution, high-sensitivity detection in a single acquisition cycle. Designed for demanding applications including intact protein analysis, peptide mapping, metabolite identification, and impurity profiling, the system meets the performance expectations of regulated and discovery laboratories requiring reproducible, GLP-compliant data generation.

Key Features

• Waters NanoAcquity UPLC module featuring Sample Manager (SM-FTN), Binary Solvent Manager (BSM), and Auxiliary Solvent Manager (ASM) for precise nanoflow and microflow LC separations
• Q-TOF Premier mass spectrometer with dual ESI/nano-ESI sources, each equipped with integrated LockSpray™ interface for real-time mass calibration and long-term stability
• Edwards XDF 35i turbo molecular vacuum pump ensuring stable high-vacuum conditions (<1×10⁻⁷ mbar) across extended acquisition periods
• Dedicated Lenovo ThinkCentre M58 workstation pre-configured with MassLynx 4.1 software, supporting full instrument control, data acquisition, processing, and reporting
• Toshiba uninterruptible power supply (UPS) model UE3G2L036C61T providing clean, regulated power to prevent data loss during transient grid fluctuations
• Fully refurbished and functionally validated unit with documented operational history (3–4 years of prior use) and comprehensive 6-month warranty covering hardware and system-level functionality

Sample Compatibility & Compliance

This LC-MS platform supports a broad range of sample types—from small-molecule pharmaceuticals and natural products to peptides, glycans, and intact monoclonal antibodies—when paired with appropriate chromatographic methods (e.g., reversed-phase, HILIC, or SEC). The nano-ESI source enables low-volume (1–10 µL), low-concentration injections typical of proteomics workflows, while the standard ESI source accommodates conventional flow rates (100–1000 µL/min). All components conform to CE marking requirements and electromagnetic compatibility (EMC) standards per IEC 61326-1. The MassLynx 4.1 software environment supports audit trail logging, user access controls, and electronic signature capabilities aligned with FDA 21 CFR Part 11 readiness—facilitating deployment in GMP and GLP environments when configured with appropriate SOPs and validation documentation.

Software & Data Management

MassLynx 4.1 provides a unified interface for method development, real-time data acquisition, centroided peak detection, and post-acquisition processing—including lock-mass correction, deconvolution (MaxEnt1), and database searching via ProteinLynx Global Server (PLGS). Raw data files (.raw) are stored in a structured, vendor-native format compatible with third-party open-source tools (e.g., ProteoWizard, Skyline) and commercial platforms (e.g., UNIFI, SimGlycan). Instrument logs, calibration reports, and maintenance records are archived within the MassLynx database, supporting traceability for regulatory audits. Backup and restore procedures follow ISO/IEC 27001-aligned data integrity practices, and system backups can be scheduled automatically to network-attached storage (NAS) or external RAID arrays.

Applications

• Peptide mapping and post-translational modification (PTM) analysis of therapeutic proteins
• Metabolite identification (MetID) in ADME studies using human or animal matrix extracts
• Impurity and degradation product characterization per ICH Q3 guidelines
• Intact mass analysis of mAbs and ADCs under native or denaturing conditions
• Non-targeted screening of environmental contaminants or food adulterants
• Structural elucidation of novel natural products via MSᴱ and HDX-MS workflows

FAQ

Is this system fully validated and ready for regulated use?
Yes—this unit has undergone functional verification including mass calibration, resolution testing, sensitivity assessment (using Glu-Fibrinopeptide B), and chromatographic performance checks (e.g., plate count, asymmetry, retention time reproducibility). Full validation documentation packages (IQ/OQ) are available upon request.
What level of technical support is included post-purchase?
SpectraLab Scientific provides remote diagnostics, application troubleshooting, and on-site service coordination through certified Waters field engineers. Extended service contracts and annual maintenance agreements are available.
Can the system be upgraded to MassLynx 4.2 or later?
Yes—MassLynx 4.1 is forward-compatible with subsequent minor releases; upgrade paths require license validation and may necessitate hardware compatibility review, which we perform prior to installation.
Are consumables and spare parts available?
All original Waters consumables—including columns, sprayers, capillaries, and calibration standards—are stocked and supplied with full traceability documentation.
Does the system include compliance-ready features for 21 CFR Part 11?
MassLynx 4.1 supports electronic signatures, role-based permissions, and immutable audit trails—however, formal Part 11 compliance requires site-specific configuration, procedural controls, and periodic review as part of a laboratory’s overall quality management system.